Clinical trial · no report yet · Phase 3
NCT00030771
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
- NCT00030771 ↗
- Completed
- Swiss Cancer Institute
- 3 commentary sources found
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built. Commentary is thin so far, so the report would be short.
| Channel | Found | |
|---|---|---|
| Podcasts | 2 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Lung Cancer
- Interventions
- Chemotherapy; Radiotherapy; Surgery
- Arms
- Arm A · Active comparator
- Arm B · Active comparator
- Enrollment
- 232
- Primary outcomes
- Event-free survival
- Sponsor
- Swiss Cancer Institute
- Start
- Apr 4, 2001
- Primary completion
- Apr 9, 2014
- Results posted
- No
- Registry record
- NCT00030771 · updated Jan 17, 2024
Publications
linked from the registry- Tieu BH, Sanborn RE, Thomas CR Jr. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin. 2008 Nov;18(4):403-15. doi: 10.1016/j.thorsurg.2008.07.004. PubMed 19086609
- Pless M, Stupp R, Ris HB, Stahel RA, Weder W, Thierstein S, Gerard MA, Xyrafas A, Fruh M, Cathomas R, Zippelius A, Roth A, Bijelovic M, Ochsenbein A, Meier UR, Mamot C, Rauch D, Gautschi O, Betticher DC, Mirimanoff RO, Peters S; SAKK Lung Cancer Project Group. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet. 2015 Sep 12;386(9998):1049-56. doi: 10.1016/S0140-6736(15)60294-X. Epub 2015 Aug 11. PubMed 26275735